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Background: From a clinical perspective, it is important to know which serogroups, virulence genes and antibiotic
resistance patterns are present in Shiga toxin-producing Escherichia coli strains in pediatric patients suffering from
diarrheic and non-diarrheic infections. This is the first study in Iran that has comprehensively investigated the Shiga
toxin-producing Escherichia coli -related infection characteristics in diarrheic and non-diarrheic pediatric patients of
0–60 months of age.
Methods: Two-hundred and twenty four diarrheic and 84 non-diarrheic stool specimens were collected from the
Baqiyatallah hospital of Tehran, Iran. The stool samples were cultured immediately and those that were E. coli-positive
were analyzed for the presence of antibiotic resistance genes and bacterial virulence factors using PCR. Antimicrobial
susceptibility testing was performed using disk diffusion method.
Results: One-hundred and fifty four out of 224 (68.75%) diarrheic stools and 31 out of 84 (36.90%) non-diarrheic stools
harbored E. coli. In addition, children in 13–24 month-old age group had the highest incidence of infection with this
bacterium (77.63%). A significant difference was found between the frequency of Attaching and Effacing Escherichia coli
and Enterohaemorrhagic Escherichia coli (P =0.045). The genes encoding Shiga toxins and intimin were the most
commonly detected virulence factors. Among all serogroups studied, O26 (27.04%) and O111 (18.85%) had the highest
incidences in the diarrheic and non-diarrheic patients. The incidence of genes encoding resistance against sulfonamide
(sul1), gentamicin (aac(3)-IV), trimethoprim (aadA1), cephalothin (blaSHV) and tetracycline (tetA) were 82.78%, 68.03%,
60.65%, 56.55% and 51.63%, respectively. High resistance levels against penicillin (100%), tetracycline (86.88%),
gentamicin (62.29%) and streptomycin (54.91%) were observed. Marked seasonality in the serogroup distributions was
evident, while STEC infections were more common in summer (P =0.041).
Conclusions: Our findings should raise awareness about antibiotic resistance in diarrheic pediatric patients in Iran.
Clinicians should exercise caution when prescribing antibiotics, especially during the warmer months of the year.
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Table 1 Incidence of E. coli isolated from diarrheic and
non-diarrheic children
Age group (Months) No. samples No. positive samples
1–12 52 36 (69.23%)
13–24 76 59 (77.63%)
25–36 39 24 (61.53%)
37–48 24 16 (66.66%)
49–60 33 19 (57.57%)
Total diarrheic samples 224 154 (68.75)
Non diarrheic 84 31 (36.90%)
Total 308 185 (60.06%)
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Infection with Shiga toxin (Stx)-producing Escherichia
coli (STEC) can result in a spectrum of outcomes, ranging
from asymptomatic carriage to uncomplicated diarrhea,
hemolytic uremic syndrome (HUS), bloody diarrhea,
hemolytic anemia, thrombocytopenia, and acute renal
failure [1-4]. High mortality and morbidity rates have been
reported for HUS, which can occur from infection with
STEC strains [1,5]. The pathogenesis of STEC is related to
several bacterial virulence factors [4,6]. Some of the most
important of these virulence factors include the intimin
(eae) protein, two shiga toxins called stx1 and stx2, and the
plasmid-encoded protein known as hemolysin (ehly) [4,6].
Most outbreaks and sporadic cases of bloody and non-
bloody diarrhea and HUS have been attributed to strains
of the STEC serogroup O157 [7,8]. However, non-O157
strains such as O26, O111, O145, O26, O91, O103, O113,
O128, O121 and O45 have been shown to cause bloody
and non-bloody diarrhea and HUS [7,8]. If diarrheic pa-
tients do not receive effective treatment, they are sus-
ceptible to secondary infections and illnesses.
Diseases caused by E. coli often require antimicrobial
therapy; however, antibiotic-resistant strains of this bac-
terium cause longer and more severe illnesses than their
antibiotic-susceptible counterparts. Several studies have
shown that antibiotic resistance in E. coli has increased
over time [8-10]. In keeping with this, an epidemiological
investigation in Iran revealed that STEC strains were the
most commonly detected strains in pediatric patients with
diarrhea and that there was a high incidence of resistance
(85–100%) to commonly used antibiotics [11,12]. Antibiotic
resistance genes are known to cause antibiotic resistance in
STEC strains isolated from diarrheic patients [13].
Data on the distribution of serogroups, virulence genes
and the antimicrobial resistance properties of STEC strains
isolated from pediatric patients are scarce in Iran [11].
Therefore, the aim of the present study was to characterize
STEC strains isolated from Iranian diarrheic and non-
diarrheic pediatric patients at the molecule level and inves-
tigate their susceptibility to 12 commonly used antibiotics,
as well as investigating seasonal variation in the prevalence
and serogroups distribution of E. coli.
Methods
Sample collection, preparation, and identification of
E. coli serogroups
From March 2012 to March 2013, a period covering
seasonal variation, 308 stool samples from diarrheic and
non-diarrheic pediatric patients were collected from the
Baqiyatallah hospital in Tehran, Iran. Stool samples were
classified as either diarrheic or non-diarrheic. Individuals
from the diarrheic group were placed into six groups
based on their ages (1–12, 13–24, 25–36, 37–48 and
49–60 month-old children) (Table 1). Information onthe clinical and epidemiological history of these patients
was obtained through questionnaires. Patients presented
at the hospital with symptoms such as nausea and fever,
while others had dysentery-like or inconsequential symp-
toms. Stool specimens were collected using sterile rectal
swabs, which were transferred to tubes containing Stuart
medium (Merck, Germany). Samples were transferred
to the Biotechnology and Microbiology Research Center
of the Islamic Azad University of Shahrekord at 4°C.
All samples were diluted in phosphate buffered saline
(PBS, Merck, Germany). The samples were plated onto
MacConkey’s agar (MC, Merck, Germany) and incubated
overnight at 37°C. A lactose positive colony was selected
from each sample, streaked onto Eosin Methylene Blue
(EMB, Merck, Germany) plates and incubated overnight at
37°C. Green colonies with a metallic luster were considered
as typical E. coli colonies. Such colonies were confirmed as
E. coli using standard biochemical tests (e.g., Methyl red,
Voges-Proskauer, Indole, and Citrate utilization tests).
Colonies were confirmed as E. coli by PCR [14]. E. coli
isolates were stored in Tryptic Soy Broth (TSB, Merck,
Germany) containing 20% glycerol at −70°C for further
characterization.
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing of the isolates was
performed using the Kirby–Bauer disc diffusion method
and Mueller–Hinton agar (Merck, Germany) according
to Clinical and Laboratory Standards Institute (CLSI)
instructions [15]. Inoculated plates were incubated aer-
obically at 37°C for 18–24 h, after which antimicrobial
susceptibility in the E. coli isolates were tested. Tetra-
cycline (30 μg/disk), ampicillin (10 u/disk), penicillin
(10 u/disk), sulfamethoxazole (25 μg/disk), streptomycin
(10 μg/disk), sulfonamide (100 μg/disk), chlorampheni-
col (30 μg/disk), gentamicin (10 μg/disk), trimethoprim
(5 μg/disk), ciprofloxacin (5 μg/disk), enrofloxacin
(5 μg/disk), cephalothin (30 μg/disk), and nitrofuran-
toin (300 μg/disk) were tested. The results were interpreted
in accordance with CLSI criteria [16]. E. coli ATCC 25922
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determination.
DNA extraction
Bacterial strains were grown overnight in Trypticase Soy
Agar (TSA, Merck, Germany) at 37°C. A single colony
was suspended in 100 μL of sterile distilled water. After
boiling the suspension for 13 min, the suspension was
frozen and centrifuged at 14,000 rpm for 15 min to
pellet the cell debris [17]. The supernatant was used as
a template for PCR amplification.
PCR detection of serogroups, virulence factors and
antibiotic resistance genes in STEC strains
To detect virulence factors, serogroups, and antibiotic
resistance genes in the E. coli isolates, different PCR
assays were used [16,18-29]. All the PCR products were
electrophoresed on 1.5% agarose gels that were strained
with ethidium bromide and examined under ultraviolet
illumination. E. coli O159:H20, O157:K88ac:H19, CAPM
6006, and CAPM 5933 strains were used as positive con-
trols and distilled water was used as a negative control.
Statistical analyses
The data were analyzed using SPSS (Statistical Package for
the Social Sciences) software and P values were calculated
using Chi-square and Fisher's exact tests to identify statisti-
cally significant relationships between the following: patient
ages, seasonal variations, patient symptoms and distribution
of virulence genes, serogroups and antibiotic resistance
properties of the STEC strains isolated from diarrheic
and non-diarrheic pediatric patients. A P value < 0.05
was considered statistically significant.
Ethical considerations
The present study was authorized by the ethical committee
of the Baqiyatallah hospital of Tehran, Iran and the
Microbiology, Biotechnology and Infectious Diseases
Center of the Islamic Azad University of Shahrekord
Branch, Iran. All patients or their parents signed the
written informed consent.
Results and discussion
All of the diarrheic and non-diarrheic stool samples were
examined using culture and PCR techniques. From 308
diarrheic and non-diarrheic stool samples, 185 (60.06%)
were positive for E. coli (Table 1). In addition, 154 out of
224 diarrheic stool samples (68.75%) and 31 out of 84
non-diarrheic stool samples (36.90%) were positive for
E. coli. The age distribution of the pediatric patients with
regard to infection with E. coli is shown in Table 1. We
found that the 13–24 month-old patients had the highest
incidence of E. coli (77.63%), while the 49–60 month-old
children had the lowest incidence (57.57%).The distribution of virulence genes in the E. coli subtypes
isolated from diarrheic and non-diarrheic pediatric patients
is shown in Table 2. We found that stx1 and eaeA were the
most commonly detected virulence genes in stool samples
from both groups of children. The Attaching and Effacing
E. coli (AEEC) subtype was the most commonly detected.
The EHEC subtype was only detected in the 13–24, 25–36,
and 49–60 month-old patients.
Table 3 shows the incidence of STEC serogroups isolated
from diarrheic and non-diarrheic patients. O26 (27.04%)
had the highest incidence, followed by O111 (18.85%). We
also found that 13–24 month-old patients had the highest
incidence of the STEC serogroups. The distribution of
antimicrobial resistance genes within the STEC serogroup
isolated from diarrheic and non-diarrheic pediatric patients
is shown in Table 4. Genes that encode resistance to sul-
fonamide, gentamicin, trimethoprim, cephalothin and tetra-
cycline antibiotics, i.e., sul1 (82.78%), aac(3)-IV (68.03%),
aadA1 (60.65%), blaSHV (56.55%) and tetA (51.63%) were
the most common antibiotic resistance genes in the diar-
rheic and non-diarrheic patients. Interestingly, we found
that O26 had the highest frequency of antibiotic resistance
genes. Antimicrobial resistance in the STEC serogroups iso-
lated from the diarrheic and non-diarrheic patients is
shown in Table 5. STEC strains exhibited the highest level
of resistance to penicillin (100%), followed by tetracycline
(86.88%), gentamicin (62.29%) and streptomycin (54.91%).
Descriptions of the seasonal profiles and clinical signs in
diarrheic children for each serogroup are shown in Table 6.
Samples that were collected in the summer had the highest
incidence of STEC serogroups, while those collected in
autumn had the lowest incidence. Children with fever
symptom had the highest incidence of STEC serogroups.
Distribution of antimicrobial resistance pattern of STEC
strains in various clinical samples are shown in Table 7.
We found that the STEC strains of dysentery and fever
samples had the highest levels of antibiotic resistance. The
highest levels of antibiotic resistance of the STEC strains
isolated from children with dysentery were found against
streptomycin, sulfamethoxazole, gentamicin, cephalothin,
nitrofurantoin and ampicillin.
Our work has identified marked seasonality in the in-
cidence of STEC serogroup strains in diarrheic and
non-diarrheic pediatric patients. There were significant
differences (P =0.041) in the incidence of STEC serogroup
strains between the hot and cold seasons of the year. One
possible explanation for the high prevalence of STEC
serogroups in summer in Iran is that climatic variables
such as heat, rain and thunderstorms, together with
variable barometric pressure may have affected the patients’
autonomic nervous systems. These variables could affect
immunity, thus making people more susceptible to in-
fections. Alternatively, the higher prevalence of STEC
serogroups may be related to higher growth rates in the
Table 2 Distribution of virulence factors in E. coli subtypes
Age (Month) Subtype No. Positive samples Virulence gene
Non detected 12 (33.66%) -
EHEC -
stx1, eaeA, ehly: -
AEEC 24 (66.66%)
1–12 (52) stx1: 18 (75.00%)
stx2: 2 (8.33%)
eaeA: 14 (58.33%)
stx1, eaeA: 15 (62.50%)
stx2, eaeA: 7 (29.16%)
stx1, stx2, eaeA: 2 (8.33%)
Total 36 (69.23%)
Non detected 18 (30.50%) -
EHEC 2 (3.38%)
stx1, eaeA, ehly: 2 (100%)
AEEC 39 (66.10%)
13–24 (76) stx1: 29 (74.35%)
stx2: 4 (10.25%)
eaeA: 24 (61.53%)
stx1, eaeA: 27 (69.23%)
stx2, eaeA: 8 (20.51%)
stx1, stx2, eaeA: 4 (10.25%)
Total 59 (77.63%)
Non detected 6 (25.00%) -
EHEC 1 (4.16%)
stx1, eaeA, ehly: 1 (100%)
AEEC 17 (70.83%)
25–36 (39) stx1: 13 (76.47%)
stx2: 2 (11.76%)
eaeA: 12 (70.58%)
stx1, eaeA: 7 (41.17%)
stx2, eaeA: 8 (47.05%)
stx1, stx2, eaeA: 2 (11.76%)
Total 24 (61.53%)
Non detected 4 (25.00%) -
EHEC stx1, eaeA, ehly: -
37–48 (24) AEEC 12 (75.00%) stx1: 8 (66.66%)
stx2: 1 (8.33%)
eaeA: 6 (50.00%)
stx1, eaeA: 6 (50.00%)
stx2, eaeA: 5 (41.66%)
stx1, stx2, eaeA: 1 (8.33%)
Total 16 (66.66%)
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Table 2 Distribution of virulence factors in E. coli subtypes (Continued)
Non detected 7 (36.84%) -
EHEC 3 (15.78%)
stx1, eaeA, ehly: 3 (100%)
AEEC 9 (47.36%)
49–60 (33) stx1: 7 (77.77%)
stx2: 1 (11.11%)
eaeA: 6 (66.66%)
stx1, eaeA: 4 (44.44%)
stx2, eaeA: 4 (44.44%)
stx1, stx2, eaeA: 1 (11.11%)
Total 19 (57.57%)




Non diarrheic (84) stx1: 12 (80.00%)
stx2: 2 (13.33%)
eaeA: 13 (86.66%)
stx1, eaeA: 7 (46.66%)
stx2, eaeA: 6 (40.00%)
stx1, stx2, eaeA: 2 (13.33%)
Total 31 (36.90%)
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care should be performed during the warmer months of
year. Of the studies that have been conducted [30,31] in
this field, all have shown a seasonal distribution for E. coli
with the highest numbers of cases occurring during the
warmer months of the year [30,31].
Data from 1996 to 2011 shows a seasonal increase in
cases from April to November in Louisiana, USA [30].
Our results show that fever was most commonly asso-
ciated with the highest incidence of STEC serogroup
types (Table 7). This finding is in accordance with the
results of Rivas et al. [32].Table 3 Incidence of Shiga toxin-producing E. coli serogroups
Age (Month) O157 O26 O103 O111
1–12 (24) - 7 2 5
13–24 (41) 2 10 3 7
25–36 (18) 1 4 2 3
37–48 (12) - 4 - -
49–60 (12) 3 2 1 2
Non diarrheic (15) - 6 - 6
Total (122) 6 (4.91%) 33 (27.04%) 8 (6.55%) 23 (18.85%) 8The most commonly infected group was 13–24 month-
old age group (77.63%), but there were no significant differ-
ences in the incidence of STEC strains among the various
age groups. In addition, 68.75% of diarrheic and 36.90%
of non-diarrheic stool samples from the children were
positive for E. coli strains; hence, the diarrheic patients
showed the higher incidence of E. coli (P = 0.022). Lower
incidence of STEC strains in Iranian diarrheic children
were reported previously by Salmanzadeh-Ahrabi et al.
[33] (15.5% incidence rate in pediatrics under 5 years old)
and Alikhani et al. [34] (8.7% incidence rate in pediatrics
under 10 years old).O145 O45 O91 O113 O121 O128
2 1 3 2 1 1
4 4 5 1 3 2
- 1 3 - 4 -
2 1 1 - 2 2
- 1 - 1 1 1
- 3 - - - -
(6.55%) 11 (9.01%) 12 (9.83%) 4 (3.27%) 11 (9.01%) 6 (4.91%)
Table 4 Distribution of antimicrobial resistance genes in Shiga toxin-producing E. coli serogroups
Serogroups aadA1 tetA tetB dfrA1 qnr aac(3)-IV sul1 blaSHV CITM cat1 cmlA
O157 (6) 2 2 2 - - 2 - 4 2 - -
O26 (33) 25 18 17 12 8 29 31 19 22 1 -
O103 (8) 4 8 - - - 3 2 5 4 - -
O111 (23) 11 7 10 8 6 16 20 12 11 - -
O145 (8) 4 6 4 6 - - 8 6 3 - -
O45 (11) 5 7 4 9 - 8 10 8 5 - -
O91 (12) 5 6 5 4 1 11 10 8 6 - 1
O113 (4) 4 2 2 - - 4 4 3 1 - -
O121 (11) 9 6 - 4 - 7 10 4 3 - -
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four bacterial virulence factors (stx1, stx2, ehly and eaeA)
in the diarrheic and non-diarrheic patients. We found
statistically significant (P =0.016) association between
the incidence of stx1 and stx2 genes in all groups and
between the EHEC and AEEC subtypes (P =0.045). In
addition, there were significant differences amongst
the incidence of virulence factors in diarrheic and non-
diarrheic patients (P =0.047). Sang et al. [35] reported
that 141 out of 380 diarrheic patients (37.1%) were
positive for E. coli and of these, ETEC, STEC, EAEC,
EIEC and EPEC strains comprised 29.8%, 24.1%, 14.2%
12.8% and 3.5%, respectively. The presence of multiple
stx1, eaeA, and ehly genes was found in the EHEC
strains isolated from 13–24 (100%), 25–36 (100%) and
49–60 month-old (100%) patients. Additionally, 13.33%
of non- diarrheic, 11.11% of 49–60 month-old diarrheic,Table 5 Antimicrobial resistance properties in Shiga toxin-pro
Serogroups TE30* S10 C30 SXT GM10 N
O157 (6) 4 2 - - 2
O26 (33) 32 24 1 29 26
O103 (8) 8 3 - 1 3
O111 (23) 16 11 - 19 14
O145 (8) 8 4 - 8 -
O45 (11) 10 5 - 11 7
O91 (12) 10 4 1 8 10
O113 (4) 4 - - 3 4
O121 (11) 9 9 - 10 7











*TE30 = tetracycline (30 μg/disk); S10 = (10 μg/disk); C30 = chloramphenicol (30 μg/d
NFX5 = enrofloxacin (5 μg/disk); CF30 = cephalothin (30 μg/disk); CIP5 = ciprofloxacin
(300 μg/disk); AM10 = ampicillin (10 u/disk); P10 = penicillin (10 u/disk).8.33% of 37–48 month-old diarrheic, 11.76% of 25–36
month-old diarrheic, 10.25% of 13–24 month-old diar-
rheic and 8.33% of 1–12 month-old diarrheic patients
harbored stx1, stx2 and eaeA genes. Similar findings have
been reported in various parts of the world including
Kenya, Korea, Australia and Brazil [35-38]. Of several
studies which were conducted in this field in Iran. Shams
et al. [39] showed that 2.8% of STEC isolates were positive
for stx1 or stx2 genes, Aslani and Bouzari [40] showed that
96.5% of STEC isolates had stx1 gene, 44.8% had hly gene,
3.5% had stx2, and 24.1% had ast1 gene and Bonyadian
et al. [41] reported that 27.6% of STEC isolates had stx1
gene, 20.7% had hly gene and 6.9% had stx2 which all was
lower than our results. These studies indicate that the stx1,
stx2, hly and eaeA genes are only present in some of the
groups studied and that the eaeA and ehly genes are asso-
ciated with diarrhea. Within the disease-associated strains,ducing E. coli serogroups
FX5 CF30 CIP5 TMP5 F/M300 AM10 P10
- 3 - - - 2 6
3 17 - 11 1 18 33
- 4 1 - - 2 8
2 11 2 8 - 8 23
- 4 - 4 1 2 8
1 7 - 8 - 2 11
1 6 - 4 - 6 12
- 2 - - - 1 4
1 2 - 3 - 3 11















isk); SXT = sulfamethoxazole (25 μg/disk); GM10 = gentamycin (10 μg/disk);
(5 μg/disk); TMP5 = trimethoprim (5 μg/disk); F/M300 = nitrofurantoin
Table 6 Seasonal distribution of serogroups and clinical signs in diarrheic children
Criteria O157 O26 O103 O111 O145 O45 O91 O113 O121 O128
(6) (27) (8) (17) (8) (8) (12) (4) (11) (6)
Spring (32) - 9 - 3 5 6 2 - 5 2
Summer (40) 4 10 3 5 2 1 7 2 3 3
(Autumn) (17) - 2 3 9 - 1 - - 1 1
Winter (18) 2 6 2 - 1 - 3 2 2 -
Nausea (42) - 7 1 6 5 5 5 3 7 3
Fever (34) 2 17 1 8 - 1 3 1 1 -
Dysentery (14) 4 3 1 - 2 - 2 - 1 1
Other clinical signs (17) - - 5 3 1 2 2 - 2 2
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to be more commonly responsible for serious compli-
cations bloody and non-bloody diarrhea and HUS than
those containing other putative bacterial pathogenic genes
[42,43].
O26 was the most commonly detected serogroup of all
of the diarrheic and non-diarrheic STEC strains. Statistical
analyses showed a significant (P =0.028) association between
the incidence of the O26 serogroup and other STEC
serogroups in all of the study groups. High differences
in the incidence of STEC serogroups between diarrheic
and non-diarrheic patients was reported previously [44,45].
Aslani and Alikhani [46] reported that O142, O111, O86
and O127 were the most commonly detected serogroups
in Iranian diarrheic children under 5 years of age which
was in contrast with our results. High presence of O55,
O26, O111, O125, O128, O114, O86, O142, O119, O127,
and O126 serogroups was reported in the STEC strains of
Alikhani et al. investigation [47].
In two studies involving 11 sites in the USA in 1997
and four sites during 1998–1999, screening of 13,798
stool samples for STEC yielded a frequency of 0.9%
(120 cases of STEC), and of these 120 cases, from the
isolates available, 54% were O157 STEC, while 46% were
non-O157 STEC [45]. Many studies have shown that O26
is the most clinically important genotype within the STEC
serogroup isolated from diarrheic and even non-diarrheicTable 7 Distribution of antimicrobial resistance pattern of Shiga
Clinical signs Antibiot
TE30 S10 C30 SXT GM10
Nausea (42) 33 (78.57) 15 (35.71) - 28 (66.66) 13 (30.95)
Fever (34) 34 (100) 22 (64.70) - 32 (94.11) 27 (79.41)
Dysentery (14) 14 (100) 14 (100) 1 (7.14) 14 (100) 14 (100) 3
Other clinical
signs (17)
17 (100) 12 (70.58) 1 (5.88) 16 (94.11) 14 (82.35) 2










(62.29%)patients [48,49] because of its association with bloody
diarrhea, non-bloody diarrhea and HUS.
Because inappropriate prescriptions of antibiotics causes
antibiotic resistance, it was not surprising that our study
found that resistance to penicillin was 100%, while resistance
to tetracycline, gentamicin and streptomycin were 86.88%,
62.29%, 54.91%, respectively. In terms of bacterial antibiotic
resistance genes, sul1 (82.78%), aac(3)-IV (68.03%), aadA1
(60.65%), blaSHV (56.55%) and tetA (51.63%) were the
most commonly detected. There were statistically sig-
nificant differences (P =0.029) amongst the incidences
of sul1, cat1 and cmlA and among aac(3)-IV, cat1 and cmlA
(P =0.041). Our results showed that the O26 serogroup
had the highest incidence of antibiotic resistance genes
and resistance to antibiotics. Our results showed that
1.63% of the STEC strains were resistance to chloram-
phenicol. Chloramphenicol is a banned antibiotic and
the slight antibiotic resistance to this drug detected in
our study indicates that irregular and unauthorized use of
it may have occurred in Iran. Similar chloramphenicol re-
sistance profiles to our own have been reported previously
[50,51]. Fazeli and Salehi [52] showed that 72.4%, 65.5%
and 58.6% of STEC strains isolated from Iranian diarrheal
patients were resistant to amoxicillin, trimethoprim-
sulfamethoxazole and tetracycline, respectively.
There were statistically significant differences (P =0.040)
amongst the incidences of antibiotic resistance in thetoxin producing Escherichia coli in various clinical samples
ic resistance pattern (%)
NFX5 CF30 CIP5 TMP5 F/M300 AM10 P10
1 (2.38) 11 (26.19) - 9 (21.42) - 10 (23.80) 42 (100)
2 (5.88) 17 (50) - 10 (29.41) - 11 (32.35) 34 (100)
(21.42) 12 (85.71) 2 (14.28) 11 (78.57) 2 (14.28) 13 (92.85) 14 (100)
(11.76) 13 (76.47) 1 (5.88) 7 (41.17) - 7 (41.17) 17 (100)
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http://www.gutpathogens.com/content/5/1/39STEC strains isolated from dysentery, fever, other clinical
signs and non-diarrheic samples. The highest incidence
of antimicrobial resistance in non-O157 STEC strains
[9] was found for sulfisoxazole (36%), tetracycline (32%),
streptomycin (29%), ampicillin (10%), trimethoprim (8%),
co-trimoxazole (8%), chloramphenicol (7%), kanamycin
(7%), piperacillin (6%) and neomycin (5%); these values
are lower than the values reported in the present study.
Jafari et al. [13] showed that diarrheagenic E. coli isolates
of Iran had high resistance against amoxicillin and tetra-
cycline (75.5%) which was similar to our results. Similar
Iranian investigations have been done previously [52-54].
Käppeli et al. [8] reported that the STEC antibiotic re-
sistance rates against ampicillin, amoxicillin/clavulanic
acid, cephalothin, cefpodoxime, cefuroxime, gentamicin,
and tetracycline were 3.1%, 12.4%, 1%, 1%, 2.1%, and 21.6%,
respectively which was similar to our findings.
Our results showed that resistance to at least one of the
12 antimicrobial drugs tested was identified in all (100%)
of the STEC strains, which is consistent with previous
studies [8-10]. Our antimicrobial resistance data are in
accordance with the results from a study in Spain, in
which 238 (41%) of 581 non-O157 STEC strains were
resistant to at least one out of the 26 antimicrobial drugs
that were tested [9].
The above data highlight large differences in the pre-
valence of STEC strains in the different studies, as well
as differences in virulence genes and antibiotic resistance
properties in the clinical samples. This could be rela-
ted to differences in the type of sample (stool, blood,
urine, meat, milk, vegetable and other clinical samples)
tested, number of samples, method of sampling, ex-
perimental methodology, geographical area, antibiotic
prescription preference among clinicians, antibiotic avail-
ability, and climate differences in the areas where the sam-
ples were collected, which would have differed between
each study.
Conclusions
In conclusion, we identified a large number of virulence
factors, serogroups, and antibiotic resistance genes and
resistance to more than one antibiotic in the STEC strains
isolated from diarrheic and non-diarrheic patients. Our
data indicate that O157 and especially non-O157 STEC
strains are predominant in Iranian diarrheic children.
Marked seasonal variation in the serogroup distribution
was also found. Our data revealed that the O26 serogroup,
the stx1, stx2, eaeA and ehly putative virulence genes, the
sul1, aac(3)-IV, aadA1, blaSHV and tetA antibiotic resis-
tance genes, and resistance to penicillin, tetracycline, genta-
micin and streptomycin were the most commonly detected
characteristics of the STEC strains isolated from Iranian
diarrheic and non-diarrheic children. Hence, judicious use
of antibiotics is required by clinicians.Abbreviations
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